Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy

Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy

Show other versions (1)

Intensive induction therapy-in acute myeloid leukemia (AML), as in some other systemic malignancies- is a strategy fundamentally different from post-remission strategies. Approaches like consolidation treatment, prolonged mainte¬nance, and autologous or allogeneic transplantation in the...

Full description

Bibliographic Details
Main Authors: Thomas Büchner, Wolfgang Hiddemann, Wolfgang E. Berdel, Bernhard Wörmann, Helmut Löffler, Claudia Schoch, Torsten Haferlach, Wolf-Dieter Ludwig, Georg Maschmeyer, Eva Lengelder, Peter Staib, Reinhard Andreesen, Leopold Balleisen, Detlef Haase, Hartmut Eimermacher, Andrea Schumacher, Carlo Aul, Herbert Rasche, Jens Uhlig, Andreas Grüneisen, Hans Edgar Reis, Joachim Hartlapp, Wolf-Dietrich Hirschmann, Hans-Josef Weh, Hermann-Josef Pielken, Winfried Gassmann, Maria-Cristina Sauerland, Achim Heinecke for the German AML Cooperative Group
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2004-07-01
Series:International Journal of Hematology-Oncology and Stem Cell Research
Subjects:
double induction
high-dose AraC
daunorubicin dosage
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4468.pdf&manuscript_id=4468

Internet

http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/4468.pdf&manuscript_id=4468

Similar Items